PET/CT IN MELANOMA

Provides up-to-dateguidance on the use of PET/CT in patientswith melanoma

Describes characteristic imaging features, normal variants, artifacts, and pitfalls

Provides informationon the relevant clinical and pathologicalbackground

Includes a series of informative teaching cases

This pocketbook provides up-to-date guidance on the use ofPET/CT in patients withmelanoma, which is of rapidly growing importance due to the emergence of immunotherapy. The role of PET/CT in diagnostic workup, staging, treatment selection, prognostication, and follow-up is clearlyexplained. Imaging features are described and illustrated with the aid of a series of teaching cases, and attention is drawn tonormal variants, artifacts,and pitfalls. Readers will also findexplanation of the relationof the clinical and pathological background to imaging and the value of PET/CT compared with conventional radiological imaging. The book is publishedwithin the Springer series Clinicians Guides to Radionuclide Hybrid Imaging (compiled under the auspices of the British NuclearMedicine Society) and willbe an excellent asset for referringclinicians, nuclear medicine/radiologyphysicians, radiographers/technologists, and nurses who routinely workin nuclear medicine and participate in multidisciplinary meetings. 

Michael S. Hofman is a nuclear medicine physicianand Associate Professor at the Centre for Cancer Imaging at the Peter MacCallumCancer Centre in Melbourne, Australia'sonly public hospital dedicated to cancertreatment, research, and education. He previously completed a PET/CT and research fellowship at Guy's& St Thomas' in London.He has a broad interest in positron emission tomography (PET), molecular imagingapplications in oncology,and radionuclide therapy, with a particular focus on novelPET radiotracers and theranosticapplications, includingneuroendocrineand prostate cancers. He currently serves as an associate editor for several journals,including Cancer Imaging, Journal of Medical Imagingand Radiation Oncology, and Leukemia Lymphoma. 

Rodney J. Hicks´is Professor of Medicine and Radiologyat the University ofMelbourne and Director of the Centre for Cancer Imaging at the Peter MacCallumCancer Centre in Melbourne, Australia.